Brian Goff, Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 8,312 shares at $32.57 ($271K) on 2024-03-05, disclosed to the SEC on 2024-03-05.
Scheduled sale ($271k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.57 | 4,156 | $135K | 50.0% |
| 2 | $32.57 | 4,156 | $135K | 50.0% |
| Total | $32.57 avg | 8,312 | $271K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $507K | — | Filing → |
| AGIO | SELL | 2025-08-12 | $813K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $1.3M | — | Filing → |